The efficacy and mechanism for action of iguratimod in primary Sj ögren’s syndrome patients

ConclusionsIguratimod alleviated symptoms and mediated adaptive-immunity balance by suppressing BAFF-R positive B cell in pSS patients.
Source: International Ophthalmology - Category: Opthalmology Source Type: research